RNAi Therapeutics: To the Liver ... and Beyond
RNAi Therapy Components Are Surviving Degradation, Staying Potent, and Reaching More Targets Than Ever
Cell Therapy Production Moves to Factory Floor
Assembly Lines Are Preparing to Churn out Safe, Reliable, and Affordable Constructs
The Top 15 Best-Selling Drugs of 2017
Amid Talk of Curbing Prices, Most Treatments Show Sales Gains
Genome Editing B.C. (Before CRISPR)
Lasting Lessons from the “Old Testament”
For full access to this article login to GEN Select now.
Boosting Potential LC/MS Operations
“Pittcon 2009” Will Highlight Emerging Trends in Both Industry and Academia
- Although mass spectrometry (MS) dates back to 1897, and high-performance liquid chromatography (LC) to the 1970s, scientists are still developing methods to enhance their capabilities. Rapid advancements in the pharmaceutical and biotechnology fields are the main drivers behind new developments. Many efforts are stemming from academic labs, which are ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.